Today during trading, shares of Biosyent Inc opened at $8.52 and closed at $8.55. prices ranged from a low of $8.52 to a high of $8.59.

The price shrank -1.04% from the previous day's close of $8.64.

During the day across North America, the TSX Composite closed -0.73% at 21740.20, the S&P 500 closed -1.20% at 5061.82, the Dow Jones Industrial Average closed -0.65% at 37735.11 and the Nasdaq Composite closed -1.79% at 15885.02.

Biosyent Inc traded under RX on the Toronto Venture Exchange (TSX-V).

A total of 1,780 shares was traded during the session, with total trades of 9, while having an average volume of 2,908 in the last five days.

Trading across the entire TSX-V saw 1,840 price advancers against 3,375 declines and 112 unchanged.

During the prior 52 weeks, RX.VN has traded as high as $9.26 (December 29,2023) and low as $7.03 (July 06,2023). Moreover, the shares have boosted 12.06 percent in the last 12 months, while they have dipped -7.27% year-to-date.

It announced a 0.04 dividend on February 07/24, with an February 28/24 ex-date and March 15/24 pay day.

Following today's trading, Biosyent Inc has a market capitalization of $100.38 million on a float of 11,618 shares outstanding. Its annual EPS is $0.53.

Biosyent Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Biosyent Inc has an average recommendation of "Moderate Buy" based on 1.00 analysts according to Zacks. From those 1 analysts, 1 have buy ratings.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..